Astellas Pharma Inc. Stock Deutsche Boerse AG
Stocks
YPHA
US04623U1025
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
02:01:50 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 12.10 EUR | +0.83% |
|
-1.63% | +9.01% |
| 08-17 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 08-10 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,190B 26.44B 22.68B 21.18B 19.43B 36.54B 2,527B 37.14B 250B 97.85B 1,267B 99.27B 97.11B | P/E 2027 * |
11.3x | P/E 2028 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 4,148B 26.17B 22.45B 20.96B 19.23B 36.17B 2,502B 36.77B 247B 96.87B 1,255B 98.28B 96.14B | EV / Sales 2027 * |
1.79x | EV / Sales 2028 * | 1.76x |
| Free-Float |
98.88% | Yield 2027 * |
3.44% | Yield 2028 * | 3.55% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.83% | ||
| 1 week | -1.63% | ||
| Current month | +5.22% | ||
| 1 month | +10.00% | ||
| 3 months | +0.83% | ||
| 6 months | -10.37% | ||
| Current year | +9.01% |
| 1 week | 11.9 |  | 12.3 |
| 1 month | 11.1 | | 12.7 |
| Current year | 10.8 | | 14.1 |
| 1 year | 8.6 | | 14.1 |
| 3 years | 7.5 | | 14.1 |
| 5 years | 7.5 | | 15.6 |
| 10 years | 7.5 | | 16.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 63 | 2019-05-31 |
| Director/Board Member | 58 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.83% | -1.63% | - | - | 25.95B | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,093B | |
| +0.85% | +4.81% | +53.77% | +58.51% | 653B | |
| +2.72% | +6.92% | +28.99% | +77.15% | 458B | |
| +1.80% | +0.52% | +41.20% | +44.05% | 355B | |
| +1.24% | +2.35% | +25.99% | +42.21% | 294B | |
| +2.07% | +2.97% | +2.27% | +13.06% | 248B | |
| +4.02% | +6.29% | +49.67% | +68.96% | 230B | |
| +1.05% | -0.02% | -13.96% | -52.13% | 203B | |
| +2.90% | +8.63% | +25.11% | +94.52% | 178B | |
| Average | +1.81% | +3.13% | +32.79% | +53.40% | 412.27B | |
| Weighted average by Cap. | +1.52% | +3.65% | +46.87% | +73.74% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,315B 14.61B 12.53B 11.7B 10.74B 20.19B 1,396B 20.52B 138B 54.07B 700B 54.85B 53.66B | 2,137B 13.48B 11.56B 10.8B 9.91B 18.63B 1,288B 18.94B 127B 49.89B 646B 50.61B 49.51B |
| Net income | 356B 2.25B 1.93B 1.8B 1.65B 3.1B 215B 3.15B 21.22B 8.31B 108B 8.43B 8.25B | 333B 2.1B 1.8B 1.68B 1.54B 2.9B 201B 2.95B 19.83B 7.77B 101B 7.88B 7.71B |
| Net Debt | -41.87B -264M -227M -212M -194M -365M -25.25B -371M -2.5B -978M -12.66B -992M -970M | -439B -2.77B -2.38B -2.22B -2.04B -3.83B -265B -3.89B -26.18B -10.25B -133B -10.4B -10.18B |
| Date | Price | Change |
|---|---|---|
| 26-08-19 | €12.10 | +0.83% |
| 26-08-18 | €12.00 | +0.84% |
| 26-08-17 | €11.90 | -3.25% |
| 26-08-14 | €12.30 | +0.82% |
| 26-08-13 | €12.20 | -0.81% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- YPHA Stock
Select your edition
All financial news and data tailored to specific country editions
